Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Symmetry Medical (SMA) Stock Forecast & Price Target

Symmetry Medical logo
Get the Latest News and Ratings for SMA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Symmetry Medical and its competitors.

Sign Up

SMA Analyst Ratings Over Time

TypeCurrent Forecast
5/6/24 to 5/6/25
1 Month Ago
4/6/24 to 4/6/25
3 Months Ago
2/6/24 to 2/5/25
1 Year Ago
5/7/23 to 5/6/24
Strong Buy
3 Strong Buy rating(s)
N/A N/A N/A
Buy
9 Buy rating(s)
N/A N/A N/A
Hold
0 Hold rating(s)
N/A N/A N/A
Sell
0 Sell rating(s)
N/A N/A N/A
Consensus Price Target$38.30N/AN/AN/A
Forecasted Upside8.13% UpsideN/AN/AN/A
Consensus Rating
Buy
N/AN/AN/A

SMA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SMA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Symmetry Medical Stock vs. The Competition

TypeSymmetry Medical CompaniesS&P 500
Consensus Rating Score
3.25
3.26
2.54
Consensus RatingBuyBuyModerate Buy
Predicted Upside6.98% Upside549.36% Upside18.10% Upside
News Sentiment Rating
Neutral News

See Recent SMA News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/29/2025National Bankshares
2 of 5 stars
 Set TargetOutperform$39.00+14.71%
4/28/2025National Bank Financial
5 of 5 stars
M. Kornack
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/28/2025Baird R W
0 of 5 stars
W. Golladay
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/28/2025Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Tricarico
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Outperform$36.00+7.62%
4/28/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Eric Luebchow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$38.00+13.60%
4/28/2025Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Hughes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$40.00+19.58%
4/28/2025BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Sanabria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$40.00+19.58%
4/28/2025Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ki Bin Kim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$38.00+13.60%
4/28/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Simon Yarmak
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$40.00+19.58%
4/28/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Mueller
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$36.00+7.62%
4/28/2025KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Todd Thomas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$38.00+13.60%
4/28/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Wesley Golladay
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$38.00+13.60%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:52 AM ET.


SMA Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Symmetry Medical is $38.30, with a high forecast of $40.00 and a low forecast of $36.00.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Symmetry Medical in the last twelve months. There are currently 9 buy ratings and 3 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SMA shares.

According to analysts, Symmetry Medical's stock has a predicted upside of 8.13% based on their 12-month stock forecasts.

Over the previous 90 days, Symmetry Medical's stock had 3 upgrades by analysts.

Analysts like Symmetry Medical less than other "" companies. The consensus rating score for Symmetry Medical is 3.25 while the average consensus rating score for "" companies is 3.26. Learn more on how SMA compares to other companies.


This page (NYSE:SMA) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners